EpiDerm™ Gene AnalysisEpiDerm genes analyzed to date are listed in table below.
Purified Total RNA from EpiDerm part numbers EPI-200 and EPI-200-HCF is now available. Each lot of RNA is characterized and provided with a quality control spec sheet including histology and Triton ET50 of the specific tissue lots, agarose gel electrophoresis of total RNA, RNA concentration, 260/280 ratio, results of G3PDH RT-PCR and TAQ-only PCR amplifications.
Control (untreated), simulated solar UVA, solar UVA+UVB and phorbol ester treated EpiDerm RNAs are available.
Inquire about pricing and other custom treatments.
Genes Analyzed To-Date |
Tech Ref No. |
constitutive
nitric oxide synthase (cNOS) |
|
Cyclooxygenase-1
(COX-1) |
235,
260
|
Cyclooxygenase-2
(COX-2) |
235,
260
|
glyceraldehyde-3-phosphate
dehydrogenase (G3PDH) |
235,
132
|
GM-CSF |
|
23-kDa
highly basic protein |
|
inducible
nitric oxide synthase (iNOS) |
261
|
Intercellular
adhesion molecule-1 (ICAM-1) |
261
|
Interleukin-1
alpha (IL-1α) |
132 |
Interleukin-1
beta (IL-1β) |
132 |
Interleukin-6
(IL-6) |
132 |
Interleukin-8
(IL-8) |
132 |
Interleukin-15
(IL-15) |
|
Interleukin-20
(IL-20) |
261 |
Interleukin-20
Receptor alpha |
|
Interleukin-20
Receptor beta |
|
5-Lipoxygenase |
|
12-Lipoxygenase |
|
15-Lipoxygense-1 |
|
15-Lipoxygense-2 |
|
Placenta
growth factors 1 and 2 (PLGF) |
235,
197 |
Ribosomal
protein S9 |
|
Thymus-
and activation-regulated chemokine (TARC) |
235 |
Tumor
necrosis factor alpha (TNF-α) |
132 |
Vascular
endothelial growth factor-A (VEGF-A) |
|
Vascular
endothelial growth factor-B (VEGF-B) |
|
Vascular
endothelial growth factor-C (VEGF-C) |
|
Vascular
endothelial growth factor-D (VEGF-D) |
|
Please contact MatTek for further information regarding treatment
conditions, primer squences and PCR conditions for specific genes
of interest.
|
